Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts

scientific article

Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/NAR/20.23.6363
P932PMC publication ID334528
P698PubMed publication ID1475197
P5875ResearchGate publication ID21680917

P2093author name stringSalles B
Calsou P
Frit P
P2860cites workProliferating cell nuclear antigen is required for DNA excision repairQ28182009
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesQ36698590
Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimerQ36968114
How Relevant is the Escherichia coli UvrABC Model for Excision Repair in Eukaryotes?Q37043242
Nucleotide excision repair in Escherichia coliQ37056044
Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined positionQ37404894
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.Q37422551
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).Q37523234
Molecular genetics of eukaryotic DNA excision repairQ38028472
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatinQ38329454
Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatinQ38340395
Substrate overlap and functional competition between human nucleotide excision repair and Escherichia coli photolyase and (a)BC excision nucleaseQ38340400
Mechanisms of cellular resistance to cisplatinQ39519222
Resistance to cisplatin and analogues: mechanisms and potential clinical implicationsQ39525356
Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract.Q40450557
Removal of psoralen monoadducts and crosslinks by human cell free extractsQ40506521
Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free systemQ40513521
RecA-dependent incision of psoralen-crosslinked DNA by (A)BC excinucleaseQ40531236
Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II).Q40538207
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationQ41202176
Cyclobutane dimers and (6-4) photoproducts in human cells are mended with the same patch sizesQ41667312
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cellsQ41687395
Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion.Q41757759
Repair of pyrimidine dimer ultraviolet light photoproducts by human cell extractsQ42159727
Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.Q43484172
DNA excision repair in cell extracts from human cell lines exhibiting hypersensitivity to DNA-damaging agentsQ44551787
An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and "second-arm" crosslink reactionsQ44756839
Conversion of monofunctional DNA adducts of cis-diamminedichloroplatinum (II) to bifunctional lesions. Effect on the in vitro replication of single-stranded DNA by Escherichia coli DNA polymerase I and eukaryotic DNA polymerases alpha.Q52454449
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).Q52832659
Role of carrier ligand in platinum resistance in L1210 cells.Q54313675
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.Q54332081
Interaction of the UvrABC endonuclease with DNA containing a psoralen monoadduct or cross-link. Differential effects of superhelical density and comparison of preincision complexesQ54687234
In vitro repair of psoralen-DNA cross-links by RecA, UvrABC, and the 5'-exonuclease of DNA polymerase I.Q54731105
Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts.Q55060652
Effect of exogenous DNA fragments on human cell extract-mediated DNA repair synthesisQ60311339
Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatinQ64390050
Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II)Q68097905
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell linesQ68343885
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNAQ69586643
Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II)Q69959332
In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replicationQ70126283
Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activityQ70791156
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cellsQ71230607
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationQ93607580
P433issue23
P407language of work or nameEnglishQ1860
P304page(s)6363-6368
P577publication date1992-12-01
P1433published inNucleic Acids ResearchQ135122
P1476titleRepair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts
P478volume20

Reverse relations

cites work (P2860)
Q36460000Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA Adducts
Q41702067Cisplatin resistance and DNA repair
Q33601030DNA damage excision repair in microplate wells with chemiluminescence detection: development and perspectives.
Q34725611DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.
Q38348382DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes
Q43955963Deregulated DNA polymerase beta strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities
Q70721567Detection of minor adducts in cisplatin-modified DNA by transcription footprinting
Q34625375Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts
Q54649579Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA.
Q40951206Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line
Q38340847High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.
Q45770163In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic
Q34282241Mechanisms of resistance to cisplatin
Q34866688Molecular aspects of resistance to antitumor platinum drugs.
Q40400417Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene
Q41886077Recognition of DNA alterations by the mismatch repair system
Q35009287Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage
Q41434234Structural studies of interactions between anticancer platinum drugs and DNA.

Search more.